CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About CADTH What We Do Programs and Services CADTH Reimbursement Review Rotigotine

Rotigotine

Last Updated: April 23, 2015

Result type: Reports

Project Number: SR0432-000

Product Line: Reimbursement Review

Generic Name: Rotigotine

Brand Name: Neupro

Manufacturer: UCB Canada Inc.

Therapeutic Area: Parkinson’s disease

Indications: Parkinson’s Disease

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: November 19, 2015

Recommendation Type: List with clinical criteria and/or conditions

Rotigotine

Files